Download PDF
Semin Neurol 2013; 33(05): 436-440
DOI: 10.1055/s-0033-1364214
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Advanced Imaging in Acute Ischemic Stroke

Shlee S. Song
1   Department of Neurology, Cedars-Sinai Medical Center, Los Angeles, California
› Author Affiliations
Further Information

Publication History

Publication Date:
06 February 2014 (online)

    Permissions and Reprints

Abstract

Advances in stroke neuroimaging have evolved from excluding acute intracranial hemorrhage on computed tomography (CT) to now using perfusion studies (PWI) and magnetic resonance imaging (MRI) to possibly expand thrombolytic treatment to patients most likely to benefit from reperfusion therapy. Advanced imaging has also helped identify those at high risk for hemorrhage and poor outcome so appropriate treatment can occur with fewer complications. Identifying those who can benefit from endovascular recanalization using advanced neuroimaging techniques is particularly useful because endovascular treatment is often initiated much later than intravenous thrombolytic treatment due to logistical constraints. Using imaging markers of tissue injury may eventually lead to a paradigm shift from time-based treatment eligibility in acute stroke reperfusion treatment as the sensitivity and specificity to identify ischemic penumbra improves and correlation with clinical outcomes becomes clearer.

Keywords

acute stroke - perfusion imaging - computed tomography - magnetic resonance imaging - reperfusion - ischemic Penumbra
 

  • References

  • 1 Barber PA, Darby DG, Desmond PM , et al. Identification of major ischemic change. Diffusion-weighted imaging versus computed tomography. Stroke 1999; 30 (10) 2059-2065
    CrossrefPubMedGoogle Scholar
  • 2 González RG, Schaefer PW, Buonanno FS , et al. Diffusion-weighted MR imaging: diagnostic accuracy in patients imaged within 6 hours of stroke symptom onset. Radiology 1999; 210 (1) 155-162
    CrossrefPubMedGoogle Scholar
  • 3 Barber PA, Hill MD, Eliasziw M , et al; ASPECTS Study Group. Imaging of the brain in acute ischaemic stroke: comparison of computed tomography and magnetic resonance diffusion-weighted imaging. J Neurol Neurosurg Psychiatry 2005; 76 (11) 1528-1533
    CrossrefPubMedGoogle Scholar
  • 4 Chalela JA, Kidwell CS, Nentwich LM , et al. Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison. Lancet 2007; 369 (9558) 293-298
    CrossrefPubMedGoogle Scholar
  • 5 Heiss WD. Flow thresholds of functional and morphological damage of brain tissue. Stroke 1983; 14 (3) 329-331
    CrossrefPubMedGoogle Scholar
  • 6 Albers GW, Thijs VN, Wechsler L , et al; DEFUSE Investigators. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol 2006; 60 (5) 508-517
    CrossrefPubMedGoogle Scholar
  • 7 Davis SM, Donnan GA, Parsons MW , et al; EPITHET investigators. Effects of alteplase beyond 3.  h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol 2008; 7 (4) 299-309
    CrossrefPubMedGoogle Scholar
  • 8 Olivot JM, Mlynash M, Thijs VN , et al. Optimal Tmax threshold for predicting penumbral tissue in acute stroke. Stroke 2009; 40 (2) 469-475
    CrossrefPubMedGoogle Scholar
  • 9 Donnan GA, Baron JC, Ma H, Davis SM. Penumbral selection of patients for trials of acute stroke therapy. Lancet Neurol 2009; 8 (3) 261-269
    CrossrefPubMedGoogle Scholar
  • 10 Mlynash M, Lansberg MG, De Silva DA , et al; DEFUSE-EPITHET Investigators. Refining the definition of the malignant profile: insights from the DEFUSE-EPITHET pooled data set. Stroke 2011; 42 (5) 1270-1275
    CrossrefPubMedGoogle Scholar
  • 11 Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995; 333 (24) 1581-1587
    CrossrefPubMedGoogle Scholar
  • 12 Hacke W, Kaste M, Bluhmki E , et al; ECASS Investigators. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008; 359 (13) 1317-1329
    CrossrefPubMedGoogle Scholar
  • 13 Inoue M, Mlynash M, Straka M , et al; DEFUSE 1 and 2 Investigators. Clinical outcomes strongly associated with the degree of reperfusion achieved in target mismatch patients: pooled data from the Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution studies. Stroke 2013; 44 (7) 1885-1890
    CrossrefPubMedGoogle Scholar
  • 14 Fisher M, Albers GW. Advanced imaging to extend the therapeutic time window of acute ischemic stroke. Ann Neurol 2013; 73 (1) 4-9
    CrossrefPubMedGoogle Scholar
  • 15 Liebeskind DS. Collateral circulation. Stroke 2003; 34 (9) 2279-2284
    CrossrefPubMedGoogle Scholar
  • 16 Harris AD, Kosior RK, Chen HS, Andersen LB, Frayne R. Evolution of hyperacute stroke over 6 hours using serial MR perfusion and diffusion maps. J Magn Reson Imaging 2009; 29 (6) 1262-1270
    CrossrefPubMedGoogle Scholar
  • 17 Nagakane Y, Christensen S, Brekenfeld C , et al; EPITHET Investigators. EPITHET: Positive Result After Reanalysis Using Baseline Diffusion-Weighted Imaging/Perfusion-Weighted Imaging Co-Registration. Stroke 2011; 42 (1) 59-64
    CrossrefPubMedGoogle Scholar
  • 18 Kidwell CS, Jahan R, Gornbein J , et al; MR RESCUE Investigators. A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med 2013; 368 (10) 914-923
    CrossrefPubMedGoogle Scholar
  • 19 Shuaib A, Butcher K, Mohammad AA, Saqqur M, Liebeskind DS. Collateral blood vessels in acute ischaemic stroke: a potential therapeutic target. Lancet Neurol 2011; 10 (10) 909-921
    CrossrefPubMedGoogle Scholar
  • 20 Broderick JP, Palesch YY, Demchuk AM , et al; Interventional Management of Stroke (IMS) III Investigators. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med 2013; 368 (10) 893-903
    CrossrefPubMedGoogle Scholar
  • 21 Ciccone A, Valvassori L ; SYNTHESIS Expansion Investigators. Endovascular treatment for acute ischemic stroke. N Engl J Med 2013; 368 (25) 2433-2434
    PubMedGoogle Scholar
  • 22 U.S. National Institutes of Health. Solitaire™ FR as primary treatment for acute ischemic stroke. http://clinicaltrials.gov/show/NCT01657461
    PubMedGoogle Scholar
  • 23 U.S. National Institutes of Health. Assess the Penumbra System in the treatment of acute stroke. http://clinicaltrials.gov/show/NCT01429350
    PubMedGoogle Scholar
  • 24 Michel P, Ntaios G, Reichhart M , et al. Perfusion-CT guided intravenous thrombolysis in patients with unknown-onset stroke: a randomized, double-blind, placebo-controlled, pilot feasibility trial. Neuroradiology 2012; 54 (6) 579-588
    CrossrefPubMedGoogle Scholar
  • 25 Thomalla G, Rossbach P, Rosenkranz M , et al. Negative fluid-attenuated inversion recovery imaging identifies acute ischemic stroke at 3 hours or less. Ann Neurol 2009; 65 (6) 724-732
    CrossrefPubMedGoogle Scholar
  • 26 U.S. National Institutes of Health. A study of intravenous thrombolysis with Alteplase in MRI-selected patients. http://clinicaltrials.gov/show/NCT01282242
    PubMedGoogle Scholar
  • 27 U.S. National Institutes of Health. Efficacy and safety of MRI-based thrombolysis in wake-up stroke. http://clinicaltrials.gov/show/NCT01525290
    PubMedGoogle Scholar
  • 28 Song SS, Latour LL, Ritter CH , et al. A pragmatic approach using magnetic resonance imaging to treat ischemic strokes of unknown onset time in a thrombolytic trial. Stroke 2012; 43 (9) 2331-2335
    CrossrefPubMedGoogle Scholar